Treating tobacco use and dependence in kidney transplant recipients: Development and implementation of a program

Shawna L. Ehlers, James R. Rodrigue, Pamela R. Patton, Joni Lloyd-Turner, Bruce Kaplan, Richard J. Howard

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Tobacco use adversely affects transplant outcomes such as graft survival, patient survival, and other conditions that alter transplant patient longevity. Especially concerning is tobacco's relationship to cardiovascular disease, the number 1 cause of death in kidney transplant recipients. Many authors conclude that tobacco interventions ought to be provided to patients and sometimes lament that there are no tobacco dependence interventions designed for kidney transplant recipients. European Best Practice Guidelines for Renal Transplantation also support tobacco dependence interventions. The purpose of this article is to describe one institution's experience in implementing the clinical practice guideline for treating tobacco use and dependence within a kidney and pancreas transplant program.

Original languageEnglish (US)
Pages (from-to)33-37
Number of pages5
JournalProgress in Transplantation
Volume16
Issue number1
StatePublished - Mar 1 2006

    Fingerprint

ASJC Scopus subject areas

  • Transplantation

Cite this

Ehlers, S. L., Rodrigue, J. R., Patton, P. R., Lloyd-Turner, J., Kaplan, B., & Howard, R. J. (2006). Treating tobacco use and dependence in kidney transplant recipients: Development and implementation of a program. Progress in Transplantation, 16(1), 33-37.